TGF-beta/Smad
VEGFR
Products > Protein Tyrosine Kinase/RTK > c-Met inhibitor > Glesatinib (MGCD-265 , MGCD265 , MGCD 265 )
|
Product name : Glesatinib (MGCD-265 , MGCD265 , MGCD 265 )
Product No. : 2017121115644
Price : 100mg/$975, 500mg/$2875
CAS :
Bulk inquiry :
|
| Details: |
Glesatinib (CAS: 936694-12-1) is an orally bioavailable, small-molecule, multitargeted tyrosine kinase inhibitor with potential antineoplastic activity. MGCD265 binds to and inhibits the phosphorylation of several receptor tyrosine kinases (RTKs), including the c-Met receptor (hepatocyte growth factor receptor); the Tek/Tie-2 receptor; vascular endothelial growth factor receptor (VEGFR) types 1, 2, and 3; and the macrophage-stimulating 1 receptor (MST1R or RON).
|
| Related Products : |
|
|
|
|
||||||||
|
|
|
|
